US$ 27.27
new indications for glp-1 drugs Medications Infographic The expanding landscape of GLP-1
Description
The Journal of Pharmacology and Experimental Therapeutics

In December 2024 tirzepatide was approved by the FDA for the treatment of moderate to severe obstructive sleep apnea in adults with obesity

American College of Cardiology

was supported by the National Cancer Institute of the National Institutes of Health under Award No

Today, GLP-1s are the most talked-about weight loss drugs in decades

We know that the drugs are safe, theyre easy to apply, and you dont need IV injections as with the antibodies. It also doesnt need to be one approach or the other
